Evidence map›Paper›PMID 33430035›Full record

SynthesisInternational journal of molecular sciences2021

Mesenchymal Stem Cell Treatment Perspectives in Peripheral Nerve Regeneration: Systematic Review.

Andrea Lavorato, Stefania Raimondo, Marina Boido, Luisa Muratori, Giorgia Durante, Fabio Cofano, Francesca Vincitorio, Salvatore Petrone, Paolo Titolo, Fulvio Tartara and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Research progress on blood therapy for anti-aging.Journal of advanced research · 2026
    Review
  11. Article
  12. Peripheral nerve repair: innovations and future directions.Journal of translational medicine · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea LavoratoNeurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10126 Turin (TO), Italy.ORCID 0000-0003-4725-0210
Stefania RaimondoDepartment of Clinical and Biological Sciences, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.ORCID 0000-0002-8907-473X
Marina BoidoDepartment of Neuroscience "Rita Levi Montalcini", Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.ORCID 0000-0003-1211-1552
Luisa MuratoriDepartment of Clinical and Biological Sciences, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.ORCID 0000-0002-4881-3313
Giorgia DuranteFaculty of Medicine and Surgery, University of Turin, 10126 Turin (TO), Italy.
Fabio CofanoNeurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10126 Turin (TO), Italy.
Francesca VincitorioNeurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10126 Turin (TO), Italy.
Salvatore PetroneNeurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10126 Turin (TO), Italy.ORCID 0000-0002-9921-3879
Paolo TitoloTraumatology-Reconstructive Microsurgery, Department of Orthopaedics and Traumatology, CTO Hospital, 10126 Turin (TO), Italy.
Fulvio TartaraNeurosurgery Unit, Istituto Clinico Città Studi (ICCS), 20131 Milan (MI), Italy.
Alessandro VercelliDepartment of Neuroscience "Rita Levi Montalcini", Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.
Diego GarbossaNeurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10126 Turin (TO), Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic peripheral nerve lesions affect hundreds of thousands of patients every year; their consequences are life-altering and often devastating and cause alterations in movement and sensitivity. Spontaneous peripheral nerve recovery is often inadequate. In this context, nowadays, cell therapy represents one of the most innovative approaches in the field of nerve repair therapies. The purpose of this systematic review is to discuss the features of different types of mesenchymal stem cells (MSCs) relevant for peripheral nerve regeneration after nerve injury. The published literature was reviewed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A combination of the keywords "nerve regeneration", "stem cells", "peripheral nerve injury", "rat", and "human" were used. Additionally, a "MeSH" research was performed in PubMed using the terms "stem cells" and "nerve regeneration". The characteristics of the most widely used MSCs, their paracrine potential, targeted stimulation, and differentiation potentials into Schwann-like and neuronal-like cells are described in this paper. Considering their ability to support and stimulate axonal growth, their remarkable paracrine activity, their presumed differentiation potential, their extremely low immunogenicity, and their high survival rate after transplantation, ADSCs appear to be the most suitable and promising MSCs for the recovery of peripheral nerve lesion. Clinical considerations are finally reported.

Indexed as

Mesenchymal Stem Cell TransplantationAnimalsCell DifferentiationHumansMesenchymal Stem CellsNerve RegenerationPeripheral NervesRatsSchwann CellsSciatic Nervemesenchymal stem cellsnerve lesionsperipheral nerve regenerationregenerative medicine

Identifiers

PMID33430035
PMCPMC7827385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.